TG Therapeutics Inc logo

TG Therapeutics Inc

FRA:NKB2 (USA)   Ordinary Shares
€ 30.94 (-0.19%) Dec 30
At Loss
P/B:
24.39
Market Cap:
€ 4.69B ($ 4.88B)
Enterprise V:
€ 4.61B ($ 4.80B)
Volume:
520.00
Avg Vol (2M):
1.01K
Trade In:

TG Therapeutics Inc Valuation Measures